TrianglePUBLICATIONS · 15337799
Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2004 Sep 1
- First author
- Berek JS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Berek JS
- type
- Author
- name
- Taylor PT
- type
- Author
- name
- Gordon A
- type
- Author
- name
- Cunningham MJ
- type
- Author
- name
- Finkler N
- type
- Author
- name
- Orr J Jr
- type
- Author
- name
- Rivkin S
- type
- Author
- name
- Schultes BC
- type
- Author
- name
- Whiteside TL
- type
- Author
- name
- Nicodemus CF
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Berek JS
- type
- Author
- name
- Taylor PT
- type
- Author
- name
- Gordon A
- type
- Author
- name
- Cunningham MJ
- type
- Author
- name
- Finkler N
- type
- Author
- name
- Orr J Jr
- type
- Author
- name
- Rivkin S
- type
- Author
- name
- Schultes BC
- type
- Author
- name
- Whiteside TL
- type
- Author
- name
- Nicodemus CF
- type
- Author
- bibliography ids
- nci-bib-c92724845330b54490d4c106
- book metadata
- content sha256
- 4e61f48cf6e5f601dc95ded7554bdb5e6eec724cc109d98fd255bcd51cb43d4f
- document type
- citation
- dois
- 10.1200/JCO.2004.09.016
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15337799
- immutable id
- pubmed:15337799@4e61f48cf6e5f601dc95ded7554bdb5e6eec724cc109d98fd255bcd51cb43d4f
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 17
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3507-16
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15337799
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 05017d14d23288f9a49add53b3645811c5a224a8f185e25cb454be17493b109a
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2004 Sep 1
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.
Preserved source evidence · Not medical advice